We can create drugs that halt or reverse aging diseases
Unity Biotechnology desires to create medication that sluggish, halt and even in some instances reverse particular illnesses of growing old, CEO Keith Leonard advised CNBC on Thursday.
Actually, he mentioned, the corporate can “completely” do it.
“The proof is mounting, each in our firm and outdoors, which you could intervene and you’ll change the course of those particular illnesses,” Leonard mentioned on “Energy Lunch.”
The corporate is concentrating on a “highly effective biology” known as mobile senescence, which is the growing old of a person cell and the way it impacts illness.
There may be already a section one trial underway for osteoarthritis, which Leonard hopes to have the outcomes for in the course of the first quarter of subsequent yr, he mentioned.
Different illnesses that might finally be handled embrace the lack of cardiac and pulmonary operate in addition to cognitive and imaginative and prescient operate — “issues we’ve come to just accept as a part of the conventional course of growing old,” he mentioned.
Within the close to future, he anticipates, illnesses could be handled as they emerge in sufferers.
“Within the far future, we will think about a world the place you’ll be able to go into the clinic a few times a yr and have your senescent cells eliminated and form of you [are] maintained in a younger, vigorous state.”
Leonard’s feedback precipitated the inventory to soar nearly 18 p.c earlier than buying and selling was halted for volatility. After buying and selling resumed a short while later, Unity Biotech shed a few of these positive aspects. It was up about eight p.c in midafternoon buying and selling.
The biotech firm, which has a market cap of $916 million, has attracted the eye of tech giants comparable to Amazon founder Jeff Bezos and PayPal co-founder Peter Thiel. Each have invested in Unity Biotech, which has acquired greater than $300 million in funding, together with $85 million raised after going public this previous Might.
— Andrew Zaleski contributed to this report.
Supply hyperlink – https://www.cnbc.com/2018/09/13/unity-biotech-we-can-create-drugs-that-halt-or-reverse-aging-diseases.html